Organon & Co. (OGN) Reports Q2 2025 Results

In This Article: Organon & Co. (NYSE:OGN) is one of the top oversold NYSE stocks to buy now. Organon & Co. (NYSE:OGN) reported its fiscal Q2 2025 results on August 5, with revenue for the quarter reaching $1.594 billion and diluted earnings per share of $0.56. A pharmacist wearing a white lab coat…